Cargando…
Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model
The HuPrime(®) human gastric neuroendocrine carcinoma derived xenograft model GA0087 was established in this study. GA0087 PDX model showed high gene expression of vascular endothelial growth factors (VEGF)-A and B, and high potential of lung metastasis. Circulating tumor cells (CTCs) with either la...
Autores principales: | Jiang, Jiahua, Wang, Daisy Dandan, Yang, Mengmeng, Chen, Dawei, Pang, Liang, Guo, Sheng, Cai, Jie, Wery, Jean-Pierre, Li, Linda, Li, Henry Qixiang, Lin, Peter Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558176/ https://www.ncbi.nlm.nih.gov/pubmed/25909226 |
Ejemplares similares
-
Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemma
por: Ribeiro, Maria João Marques, et al.
Publicado: (2018) -
Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy
por: Tran, Catherine G., et al.
Publicado: (2022) -
Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signature
por: Guo, Sheng, et al.
Publicado: (2016) -
A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy
por: Zhang, Lianhai, et al.
Publicado: (2013) -
Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer
por: Zhu, Yan, et al.
Publicado: (2015)